WellSpan Health - Ephrata — Ephrata, Pennsylvania

WellSpan Health - Ephrata is a clinical research site located in Ephrata, Pennsylvania, United States 17522.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

WellSpan Health - Ephrata has participated in 1 clinical trials.

Therapeutic areas: Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Stage III, Recurrent Non Small Cell Lung Cancer.

Sponsors: NRG Oncology.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for WellSpan Health - Ephrata?

WellSpan Health - Ephrata has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has WellSpan Health - Ephrata conducted?

WellSpan Health - Ephrata has 1 clinical trials on record. Their work covers Non-small Cell Lung Cancer, Non-small Cell Lung Cancer Stage III, Recurrent Non Small Cell Lung Cancer.

Is WellSpan Health - Ephrata accredited by Crixeo Health?

WellSpan Health - Ephrata has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about WellSpan Health - Ephrata?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.